ArticleFrontiers in endocrinology2024

Effectiveness and safety of glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes: evidence from a retrospective real-world study.

Yan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.